FDA drug development initiative
Executive Summary
FDA's initiative to accelerate development of new drugs will be a topic of the agency's Science Board meeting on April 22. The "Critical Path" initiative will redirect research funding towards identifying major barriers to drug development (1"The Pink Sheet" March 22, 2004, p. 30)...